Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biqi Chen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Child Neurology Open|May 16, 2017
Seizures Related to Hypomagnesemia: A Case Series and Review of the LiteratureBecky Biqi Chen, Chitra Prasad, Marta Kobrzynski, et al.
Melanoma Research|November 8, 2023
Management of metastatic bone disease of melanomaWenyan Chen, Chen Yang, Biqi Chen, et al.
American Journal of Clinical Pathology|June 27, 2024
The role of upper gastrointestinal endoscopy in the diagnosis of pediatric inflammatory bowel diseaseBecky Biqi Chen, Zachary Hamilton, Mohammed Hasosah, et al.
Npj Imaging|July 2, 2025
Label-free live cell recognition and tracking for biological discoveries and translational applicationsBiqi Chen, Zi Yin, Billy Wai-Lung Ng, et al.
Nature Communications|March 1, 2024
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimabBaoqing Chen, Shiliang Liu, Yujia Zhu, et al.
Cancer Research and Treatment|May 5, 2026
Concurrent Chemoradiotherapy with or without Induction Chemoimmunotherapy in Unresectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World StudyBiqi Chen, Peiying Cen, Qi Cheng, et al.
Annals of Medicine|February 2, 2026
Adding anti-PD-1 antibody to definitive chemoradiotherapy in elderly patients with esophageal squamous cell carcinoma: higher intensity does not equate to better outcomesPeiying Cen, Biqi Chen, Wenxi Zhou, et al.
Cancer Biology & Medicine|April 16, 2026
Machine learning-based clinical decision support tool for advanced ESCC in the immunotherapy era: a multi-center studyHui Bai, Xiaofeng Wang, Qifeng Wang, et al.
Journal for Immunotherapy of Cancer|January 12, 2026
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trialsBaoQing Chen, Junying Chen, Sifen Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2024
Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching AnalysisBiqi Chen, Wenyan Chen, Qi Cheng, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Child Neurology Open|May 16, 2017
Seizures Related to Hypomagnesemia: A Case Series and Review of the LiteratureBecky Biqi Chen, Chitra Prasad, Marta Kobrzynski, et al.
Melanoma Research|November 8, 2023
Management of metastatic bone disease of melanomaWenyan Chen, Chen Yang, Biqi Chen, et al.
American Journal of Clinical Pathology|June 27, 2024
The role of upper gastrointestinal endoscopy in the diagnosis of pediatric inflammatory bowel diseaseBecky Biqi Chen, Zachary Hamilton, Mohammed Hasosah, et al.
Npj Imaging|July 2, 2025
Label-free live cell recognition and tracking for biological discoveries and translational applicationsBiqi Chen, Zi Yin, Billy Wai-Lung Ng, et al.
Nature Communications|March 1, 2024
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimabBaoqing Chen, Shiliang Liu, Yujia Zhu, et al.
Cancer Research and Treatment|May 5, 2026
Concurrent Chemoradiotherapy with or without Induction Chemoimmunotherapy in Unresectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World StudyBiqi Chen, Peiying Cen, Qi Cheng, et al.
Annals of Medicine|February 2, 2026
Adding anti-PD-1 antibody to definitive chemoradiotherapy in elderly patients with esophageal squamous cell carcinoma: higher intensity does not equate to better outcomesPeiying Cen, Biqi Chen, Wenxi Zhou, et al.
Cancer Biology & Medicine|April 16, 2026
Machine learning-based clinical decision support tool for advanced ESCC in the immunotherapy era: a multi-center studyHui Bai, Xiaofeng Wang, Qifeng Wang, et al.
Journal for Immunotherapy of Cancer|January 12, 2026
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trialsBaoQing Chen, Junying Chen, Sifen Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2024
Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching AnalysisBiqi Chen, Wenyan Chen, Qi Cheng, et al.
Pageof 2